Top

Published in:

01-04-2014 | Original Article

Expression of hedgehog signalling pathway in anaplastic thyroid cancer

Authors: Ulrike Hinterseher, Annette Wunderlich, Silvia Roth, Annette Ramaswamy, Detlef K. Bartsch, Stefan Hauptmann, Brandon H. Greene, Volker Fendrich, Sebastian Hoffmann

Published in: Endocrine | Issue 3/2014

Abstract

The purpose of this work is to study the activation of the hedgehog signalling pathway is associated with tumour progression in various types of cancer, hence the development of specific antagonists raises hope for new therapeutic strategies. Therefore, the expression of hedgehog pathway components in anaplastic thyroid cancer (ATC) and effects of the hedgehog inhibitor Cyclopamine on ATC cells were investigated in this study. Expression of the ligand Sonic Hedgehog (SHh), the transmembrane protein Smoothened (Smo), the receptor Patched (Ptc) and the target gene Gli-1 was evaluated in two ATC cell lines (Hth 74, C643) by RT-PCR and in tumour specimens by immunohistochemistry. The corresponding gene products were examined by western blotting analysis. After treatment with different concentrations of Cyclopamine the time-dependent course of cell viability in ATC cell lines was evaluated by MTT assay. SHh, Smo, Ptc and Gli were clearly expressed on mRNA and protein levels in both cell lines and in tumour samples (41 %SHh, 65 %Smo, 65 %Ptc and 65 %Gli). Treatment with Cyclopamine showed a time- and dose-dependent inhibition of cell numbers with IC50 values between 1 and 4 μM in both cell lines, comparable to other types of cancer. In conclusion, we believe that the hedgehog pathway is expressed in anaplastic thyroid carcinoma specimens and proliferation of ATC cell lines can be influenced by the Hh inhibitor Cyclopamine. Aberrant activation of this pathway might be involved in the aggressive biology of anaplastic cancer and further evaluation regarding a possible clinical impact of pathway inhibition is warranted.

B. Aschebrook-Kilfoy, M.H. Ward, M.M. Sabra, S.S. Devesa, Thyroid cancer incidence patterns in the United States by histologic type, 1992–2006. Thyroid 21(2), 125–134 (2011). doi:10.1089/thy.2010.0021 PubMedCentralPubMedCrossRef

F. Perri, G.D. Lorenzo, G.D. Scarpati, C. Buonerba, Anaplastic thyroid carcinoma: a comprehensive review of current and future therapeutic options. World J. Clin. Oncol. 2(3), 150–157 (2011). doi:10.5306/wjco.v2.i3.150 PubMedCentralPubMedCrossRef

Y.H. Bian, S.H. Huang, L. Yang, X.L. Ma, J.W. Xie, H.W. Zhang, Sonic hedgehog-Gli1 pathway in colorectal adenocarcinomas. World J. Gastroenterol. 13(11), 1659–1665 (2007)PubMed

J. Dong, M.R. Gailani, S.L. Pomeroy, D. Reardon, A.E. Bale, Identification of PATCHED mutations in medulloblastomas by direct sequencing. Hum. Mutat. 16(1), 89–90 (2000). doi:10.1002/1098-1004(200007)16:1<89:AID-HUMU18>3.0.CO;2-7 PubMedCrossRef

L. Ghali, S.T. Wong, J. Green, N. Tidman, A.G. Quinn, Gli1 protein is expressed in basal cell carcinomas, outer root sheath keratinocytes and a subpopulation of mesenchymal cells in normal human skin. J. Invest. Dermatol. 113(4), 595–599 (1999). doi:10.1046/j.1523-1747.1999.00729.x PubMedCrossRef

K.T. Jang, K.T. Lee, J.G. Lee, S.H. Choi, J.S. Heo, D.W. Choi, G. Ahn, Immunohistochemical expression of Sonic hedgehog in intraductal papillary mucinous tumor of the pancreas. Appl. Immunohistochem. Mol. Morphol. 15(3), 294–298 (2007). doi:10.1097/01.pai.0000213132.71041.da PubMedCrossRef

M.S. Liu, P.Y. Yang, T.S. Yeh, Sonic hedgehog signalling pathway in pancreatic cystic neoplasms and ductal adenocarcinoma. Pancreas 34(3), 340–346 (2007). doi:10.1097/mpa.0b013e3180333ab5 PubMedCrossRef

Z. Yuan, J.A. Goetz, S. Singh, S.K. Ogden, W.J. Petty, C.C. Black, V.A. Memoli, E. Dmitrovsky, D.J. Robbins, Frequent requirement of hedgehog signalling in non-small cell lung carcinoma. Oncogene 26(7), 1046–1055 (2007). doi:10.1038/sj.onc.1209860 PubMedCrossRef

J.E.S. Hooper, M.P. Scott, The drosophila patched gene encodes a putative membrane protein required for segmental patterning. Cell 59(4), 751–765 (1989)PubMedCrossRef

10.

V. Marigo et al., Biochemical evidence that patched is the hedgehog receptor. Nature 384, 177–179 (1996)CrossRef

11.

P.T. Chuang, A.P. McMahon, Vertebrate hedgehog signalling modulated by induction of a hedgehog-binding protein. Nature 397(6720), 617–621 (1999). doi:10.1038/17611 PubMedCrossRef

12.

L.V. Goodrich, L. Milenkovic, K.M. Higgins, M.P. Scott, Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277(5329), 1109–1113 (1997)PubMedCrossRef

13.

A. Ruiz i Altaba, C. Mas, B. Stecca, The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol. 17(9), 438–447 (2007). doi:10.1016/j.tcb.2007.06.007 PubMedCentralPubMedCrossRef

14.

B. Stecca, I.A.A. Ruiz, Context-dependent regulation of the GLI code in cancer by hedgehog and non-hedgehog signals. J. Mol. Cell Biol. 2(2), 84–95 (2010). doi:10.1093/jmcb/mjp052 PubMedCentralPubMedCrossRef

15.

H. Kimura, D. Stephen, A. Joyner, T. Curran, Gli1 is important for medulloblastoma formation in Ptc1 ± mice. Oncogene 24(25), 4026–4036 (2005). doi:10.1038/sj.onc.1208567 PubMedCrossRef

16.

N. Dahmane, J. Lee, P. Robins, P. Heller, A. Ruiz i Altaba, Activation of the transcription factor Gli1 and the Sonic hedgehog signalling pathway in skin tumours. Nature 389(6653), 876–881 (1997). doi:10.1038/39918 PubMedCrossRef

17.

K.K. Nelson, P. Gattuso, X. Xu, R.A. Prinz, Expression of the sonic hedgehog pathway molecules in synchronous follicular adenoma and papillary carcinoma of the thyroid gland in predicting malignancy. Surgery 148(4), 654–660 (2010). doi:10.1016/j.surg.2010.07.030. discussion 660PubMedCrossRef

18.

X. Xu, H. Ding, G. Rao, S. Arora, C.P. Saclarides, J. Esparaz, P. Gattuso, C.C. Solorzano, R.A. Prinz, Activation of the Sonic hedgehog pathway in thyroid neoplasms and its potential role in tumor cell proliferation. Endocr. Relat. Cancer 19(2), 167–179 (2012). doi:10.1530/erc-11-0305 PubMedCrossRef

19.

J. Taipale, J.K. Chen, M.K. Cooper, B. Wang, R.K. Mann, L. Milenkovic, M.P. Scott, P.A. Beachy, Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine. Nature 406(6799), 1005–1009 (2000). doi:10.1038/35023008 PubMedCrossRef

20.

D.M. Berman, S.S. Karhadkar, A.R. Hallahan, J.I. Pritchard, C.G. Eberhart, D.N. Watkins, J.K. Chen, M.K. Cooper, J. Taipale, J.M. Olson, P.A. Beachy, Medulloblastoma growth inhibition by hedgehog pathway blockade. Science 297(5586), 1559–1561 (2002). doi:10.1126/science.1073733 PubMedCrossRef

21.

S.P. Thayer, M.P. di Magliano, P.W. Heiser, C.M. Nielsen, D.J. Roberts, G.Y. Lauwers, Y.P. Qi, S. Gysin, C. Fernandez-del Castillo, V. Yajnik, B. Antoniu, M. McMahon, A.L. Warshaw, M. Hebrok, Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425(6960), 851–856 (2003). doi:10.1038/nature02009 PubMedCentralPubMedCrossRef

22.

M. Lauth, A. Bergstrom, T. Shimokawa, R. Toftgard, Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl. Acad. Sci. USA 104(20), 8455–8460 (2007). doi:10.1073/pnas.0609699104 PubMedCentralPubMedCrossRef

23.

N.E. Heldin, B. Westermark, The molecular biology of the human anaplastic thyroid carcinoma cell. Thyroidology 3(3), 127–131 (1991)PubMed

24.

A. Steg, H.M. Amm, Z. Novak, A.R. Frost, M.R. Johnson, Gli3 mediates cell survival and sensitivity to cyclopamine in pancreatic cancer. Cancer Biol. Ther. 10(9), 893–902 (2010). doi:10.4161/cbt.10.9.13252 PubMedCentralPubMedCrossRef

25.

S.M. Wiseman, O.L. Griffith, S. Deen, A. Rajput, H. Masoudi, B. Gilks, L. Goldstein, A. Gown, S.J. Jones, Identification of molecular markers altered during transformation of differentiated into anaplastic thyroid carcinoma. Arch. Surg. 142(8), 717–727 (2007). doi:10.1001/archsurg.142.8.717. discussion 727–719PubMedCrossRef

26.

A.R. Jonckheere, A distribution-free k-sample test against ordered alternatives. Biometrica 41, 133–145 (1954)

27.

M.H. Hasler, L.A. Hothorn, Multiple contrast tests in the presence of heteroscedasticity. Biom. J. 50, 793–800 (2008)PubMedCrossRef

28.

N. Ting (ed.), Dose finding in drug developement (Springer, New York, 2006)

29.

R. Bhattacharya, J. Kwon, B. Ali, E. Wang, S. Patra, V. Shridhar, P. Mukherjee, Role of hedgehog signalling in ovarian cancer. Clin. Cancer Res. 14(23), 7659–7666 (2008). doi:10.1158/1078-0432.ccr-08-1414 PubMedCrossRef

30.

V. Dormoy, S. Danilin, V. Lindner, L. Thomas, S. Rothhut, C. Coquard, J.J. Helwig, D. Jacqmin, H. Lang, T. Massfelder, The sonic hedgehog signalling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth. Mol. Cancer 8, 123 (2009). doi:10.1186/1476-4598-8-123 PubMedCentralPubMedCrossRef

31.

G.A. Raz, K.E. Allen, C. Kingsley, I. Cherni, S. Arora, A. Watanabe, C.D. Lorenzo, V.D.K. Edwards, S. Sridhar, G. Hostetter, G.J. Weiss, Hedgehog signalling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer. Lung Cancer 76(2), 191–196 (2011)PubMedCrossRef

32.

V. Fendrich, J. Waldmann, F. Esni, A. Ramaswamy, M. Mullendore, M. Buchholz, A. Maitra, G. Feldmann, Snail and Sonic hedgehog activation in neuroendocrine tumors of the ileum. Endocr. Relat. Cancer 14(3), 865–874 (2007). doi:10.1677/erc-07-0108 PubMedCrossRef

33.

D.M. Berman, S.S. Karhadkar, A. Maitra, R. Montes De Oca, M.R. Gerstenblith, K. Briggs, A.R. Parker, Y. Shimada, J.R. Eshleman, D.N. Watkins, P.A. Beachy, Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425(6960), 846–851 (2003). doi:10.1038/nature01972 PubMedCrossRef

34.

D.N. Watkins, D.M. Berman, S.G. Burkholder, B. Wang, P.A. Beachy, S.B. Baylin, Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422(6929), 313–317 (2003). doi:10.1038/nature01493 PubMedCrossRef

35.

L. Mao, Y.P. Xia, Y.N. Zhou, R.L. Dai, X. Yang, S.J. Duan, X. Qiao, Y.W. Mei, B. Hu, H. Cui, A critical role of Sonic Hedgehog signalling in maintaining the tumorigenicity of neuroblastoma cells. Cancer Sci. 100(10), 1848–1855 (2009). doi:10.1111/j.1349-7006.2009.01262.x PubMedCrossRef

36.

T. Kawahara, N. Kawaguchi-Ihara, Y. Okuhashi, M. Itoh, N. Nara, S. Tohda, Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells. Anticancer Res. 29(11), 4629–4632 (2009)PubMed

37.

P.M.R. LoRusso, C.M. Rudin, J.R. Reddy et al., Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors. Clin. Cancer Res. 17(8), 2502–2511 (2011)PubMedCrossRef

38.

E.A. Barnes, K.J. Heidtman, D.J. Donoghue, Constitutive activation of the shh-ptc1 pathway by a patched1 mutation identified in BCC. Oncogene 24(5), 902–915 (2005). doi:10.1038/sj.onc.1208240 PubMedCrossRef

39.

J. Reifenberger, M. Wolter, C.B. Knobbe, B. Kohler, A. Schonicke, C. Scharwachter, K. Kumar, B. Blaschke, T. Ruzicka, G. Reifenberger, Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br. J. Dermatol. 152(1), 43–51 (2005). doi:10.1111/j.1365-2133.2005.06353.x PubMedCrossRef

40.

O. Munoz, F. Fend, R. de Beaumont, H. Husson, A. Astier, A.S. Freedman, TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin’s lymphoma and effect on cell proliferation. Leukemia 18(12), 2015–2025 (2004). doi:10.1038/sj.leu.2403485 PubMedCrossRef

41.

E.G. Rizzatti, R.P. Falcao, R.A. Panepucci, R. Proto-Siqueira, W.T. Anselmo-Lima, O.K. Okamoto, M.A. Zago, Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3 K-AKT, WNT and TGFbeta signalling pathways. Br. J. Haematol. 130(4), 516–526 (2005). doi:10.1111/j.1365-2141.2005.05630.x PubMedCrossRef

42.

S. Dennler, J. Andre, I. Alexaki, A. Li, T. Magnaldo, P. ten Dijke, X.J. Wang, F. Verrecchia, A. Mauviel, Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res. 67(14), 6981–6986 (2007). doi:10.1158/0008-5472.can-07-0491 PubMedCrossRef

43.

R. Elisei, Anaplastic thyroid cancer therapy: dream or reality? Endocrine 42(3), 468–470 (2012)PubMedCrossRef

Title: Expression of hedgehog signalling pathway in anaplastic thyroid cancer
Authors: Ulrike Hinterseher
Annette Wunderlich
Silvia Roth
Annette Ramaswamy
Detlef K. Bartsch
Stefan Hauptmann
Brandon H. Greene
Volker Fendrich
Sebastian Hoffmann
Publication date: 01-04-2014
Publisher: Springer US
Published in: Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-013-0015-y

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2014

Incidental medullary thyroid microcarcinoma revealed by mild increase of preoperative serum calcitonin levels: therapeutic implications

Changes in levels of peripheral hormones controlling appetite are inconsistent with hyperphagia in leptin-deficient subjects

Circulating chemerin decreases in response to a combined strength and endurance training

Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis

The association of SCGB3A2 polymorphisms with the risk of Graves’ disease: a meta-analysis

Association of the ATM gene polymorphisms with papillary thyroid cancer

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage